Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Pulmonary/Respiratory Diseases | Trauma (Emergency, Injury, Surgery) | Family Medicine

Clinical Trials: Lung Injury


A listing of clinical trials currently looking for volunteers to enroll in Lung Injury studies. Click on the closest city to find more detailed information on a research study in your area.

California

Duarte : City of Hope

IBV Valve System, A Humanitarian Use Device Intended to Control Prolonged Air Leaks

Colorado

Denver : University of Colorado / National Jewish Health

Study of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure

Kentucky

Lexington : GSK Investigational Site

SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS

Massachusetts

Springfield : Baystate Critical Care Medicine / Tufts University School of Medicine

Study of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure

Michigan

Ann Arbor : University of Michigan

Study of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure

Minnesota

Rochester : Mayo Clinic

PICCO Study: Risk Prediction and Early Detection of Perioperative Acute Lung Injury

Rochester : Mayo Clinic

Prospective, Randomized, Blinded, Placebo-controlled, Multi-center Trial of Omega-3 Fatty Acid, Gamma-Linolenic Acid, and Anti-Oxidant Supplementation in the Management of Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS)

Rochester : Mayo Clinic

SCD40L & TXA2: Mechanistic Evaluation of Postoperative Acute Lung Injury

Rochester : Mayo Clinic

Transfusion-Related Acute Lung Injury (TRALI): Incidence and Mechanisms

North Carolina

Durham : GSK Investigational Site

SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS

Winston-Salem : Wakeforest University, School of Medicine

Study of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure

Ohio

Columbus : Ohio State University Medical Center

Study of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure

Oregon

Portland : The Oregon Clinic

Study of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure

Pennsylvania

Philadelphia : GSK Investigational Site

SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS

Philadelphia : University of Pennsylvania Medical Center

Study of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure

Philadelphia : GSK Investigational Site

The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury

Pittsburgh : GSK Investigational Site

SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS

Pittsburgh : University of Pittsburgh Medical Center

Study of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure

Tennessee

Nashville : GSK Investigational Site

SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS

Vermont

Burlington : University of Vermont College of Medicine

Study of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure

United Kingdom

Harrow : GSK Investigational Site

Safety Study of GSK1995057 Given as Single and Repeat Intravenous Doses in Healthy Subjects.